Company

About

ChitogenX

ChitogenX

16667 boul. Hymus, Kirkland, Québec H9H 4R9, CA

Headquartered in Kickland, Quebec, ChitogenX Inc. (formally Ortho Regenerative Technologies Inc.) is a clinical stage regenerative medicine company dedicated to the development of novel therapeutic tissue repair technologies to improve tissue healing. The Company is committed to the clinical development of its proprietary RESTORE technology platform, a muco-adhesive CHITOSAN based biopolymer matrix, specifically designed to deliver biologics such as platelet-rich plasma (PRP) or bone marrow aspirate concentrate (BMAC), to enhance healing in various musculoskeletal conditions. ORTHO-R, its lead Chitosan-PRP hybrid biologic implant combination product, is formulated and designed to increase the healing rates of occupational and sports related injuries to tendons, ligaments, and cartilage such as the meniscus. ORTHO-R can be directly and easily applied to the site of injury by a surgeon during a routine operative procedure with minimal disruption to length of surgery. ORTHO-R is currently the object of an ongoing U.S. Phase I/II clinical trial for rotator cuff tear repair in 10 U.S. based clinical centers. Other formulations are being developed to leverage the technology's performance characteristics such as tissue adhesion, pliability, and ability to deliver biologics or therapeutics to various tissues damaged by trauma or disease. Further information about Chitogenx is available on the Company's website at www.chitogenx.com and on SEDAR at www.sedar.com.

Covalon Technologies Ltd.

Covalon Technologies Ltd.

1660 Tech Ave #5, Mississauga, Ontario L4W5S7, CA

Covalon is a leading provider of compassionate care solutions that help patients heal faster and live better. We are a patient-driven medical device company, with a strong portfolio of patented technologies and solutions for advanced wound care, infection prevention and medical device coatings. We offer innovative, gentler and more compassionate options for patients to heal with less infections, less pain and better outcomes, because we care.

Kane Biotech

Kane Biotech

Winnipeg, Canada

With 81 patents and patents pending, Kane Biotech is Kane Biotech is THE Biofilm Company. Creating smarter ways to fight bacteria, Kane is leading the advancement of technologies and products that break up biofilms and destroy bacteria. Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. StrixNB™, DispersinB®, Aledex™, bluestem™, bluestem®, silkstem™, goldstem™, coactiv+™, coactiv+®, DermaKB™ and DermaKB Biofilm™ are trademarks of Kane Biotech Inc. The Company is listed on the TSX Venture Exchange under the symbol "KNE" and on the OTCQB Venture Market under the symbol "KNBIF".

MolecuLight

MolecuLight

425 University Ave, Suite 700, Toronto, Ontario M5G 1T6, CA

MolecuLight Inc. a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s suite of commercially released devices, including the MolecuLight i:X® and DX™ fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden > 10^4 CFU/g (when used with clinical signs and symptoms) and for digital wound measurement #moleculight